The M1 muscarinic receptor is thought to be an important therapeutic target in schizophrenia. A cell-based fluorometric calcium assay was developed for high throughput screening. This assay was used to identify compounds with high selectivity for the M1 receptor subtype that act at an allosteric site on the receptor, thus providing increased specificity for this single receptor subtype. It is anticipated that these compounds will provide important tools for the study of muscarinic receptor function in the CNS. Agents that enhance cholinergic transmission or activate muscarinic acetylcholine receptors (mAChRs) have been developed to ameliorate the loss of cognitive function in patients with Alzheimer's Disease (AD). While cholinergic agents have been partially successful in improving cognitive function in AD patients, the most exciting findings coming from clinical studies with these agents have been the demonstration of efficacy in reducing psychotic symptoms in patients with AD and other neurodegenerative disorders. Interestingly, the M1/M4 preferring mAChR agonist, xanomeline, also induces a robust antipsychotic effect in schizophrenic patients, suggesting that mAChR agonists may have broad utility in reducing psychotic symptoms in patients suffering from schizophrenia and certain neurodegenerative disorders. Evidence suggests that the antipsychotic effects of cholinergic agents may be mediated by the M1 mAChR subtype. However, previous compounds developed to selectively activate M1 receptors have failed in clinical development due to a lack of true specificity for M1 and adverse effects associated with activation of other mAChR subtypes. Furthermore, the lack of highly selective compounds has made it impossible to definitively determine whether the behavioral and clinical effects of these compounds are mediated by M1 and the M4 receptor subtype is also a viable candidate for mediating the antipsychotic effects. Previous attempts to develop agonists and antagonists that are highly selective for M1 or other specific mAChR subtypes have failed because of the high conservation of the ACh binding site and difficulty in developing compounds that are truly specific. However, in recent years, major advances have been made in discovery of highly selective antagonists of other G protein-coupled receptors (GPCRs) that act at allosteric sites rather than the orthosteric neurotransmitter binding site [1, 2]. These compounds induce a noncompetitive blockade of receptor function and tend to be highly selective for the targeted receptor. Even more promising for discovery of M1-selective agonists, novel compounds have now been discovered that act at an allosteric site on M1 receptor rather than the orthosteric ACh-binding site to induce a robust activation of the receptor and provide high receptor subtype specificity [3, 4]. The purpose of this assay was to test the lead compound against a broad panel of targets to determine ancillary activity. MDS Pharma (The Triad, 2200 Renaissance Blvd, Suite 400, King of Prussia, PA 19406-2755) performed a Lead Profiling Screen of GPCRs, ion channels and transporters against the compound at 10uM concentration. The compond possessed a superior ancillary profile with only three activities >50% at 10 uM, and was thus declared an MLSCN probe.
bao:BAO_0000541 "626" ; # "is counter assay of" -> "626"
bao:BAO_0000812 "1798" ; # "has summary assay" -> "1798"
bao:BAO_0000210 bao:BAO_0000032 ; # "has assay stage" -> "secondary assay"
bao:BAO_0001070 bao:BAO_0001064 ; # "has alternate target assay" -> "alternate target assay"
bao:BAO_0000205 bao:BAO_0000217 ; # "has assay format" -> "biochemical format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000284 ; # "has participant" -> "G protein coupled receptor" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0000212 bao:BAO_0000123 ; # "has assay method" -> "binding assessment method"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Novel allosteric agonists of the M1 muscarinic receptor" ; # "screening campaign name" -> "Novel allosteric agonists of the M1 muscarinic receptor"
bao:BAO_0002853 "Discovery of novel allosteric modulators of the M1 muscarinic receptor: Agonist Ancillary Activity" ; # "has assay title" -> "Discovery of novel allosteric modulators of the M1 muscarinic receptor: Agonist Ancillary Activity"
bao:BAO_0003105 <http://purl.obolibrary.org/obo/GO_0005488> ; # "has function" -> "binding"
bao:BAO_0002863 bao:BAO_0000536 ; # "has concentration throughput" -> "single concentration"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Jeffery P. Conn" ; # "material entity assay provider" -> "Jeffery P. Conn" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000372 ; # "has assay phase characteristic" -> "homogeneous phase"
bao:BA0_0090012 "adenosine A1 receptor [Homo sapiens]" ; # "has participant" -> "adenosine A1 receptor [Homo sapiens]"
bao:BA0_0090012 "adenosine A2a receptor [Homo sapiens]" ; # "has participant" -> "adenosine A2a receptor [Homo sapiens]"
bao:BA0_0090012 "adenosine A3 receptor [Homo sapiens]" ; # "has participant" -> "adenosine A3 receptor [Homo sapiens]"
bao:BA0_0090012 "\"adrenergic, alpha-1A-, receptor [Rattus norvegicus]\"" ; # "has participant" -> ""adrenergic, alpha-1A-, receptor [Rattus norvegicus]""
bao:BA0_0090012 "\"adrenergic, alpha-1B-, receptor [Rattus norvegicus]\"" ; # "has participant" -> ""adrenergic, alpha-1B-, receptor [Rattus norvegicus]""
bao:BA0_0090012 "alpha-1D-adrenergic receptor [Homo sapiens]" ; # "has participant" -> "alpha-1D-adrenergic receptor [Homo sapiens]"
bao:BA0_0090012 "alpha-2A-adrenergic receptor [Homo sapiens]" ; # "has participant" -> "alpha-2A-adrenergic receptor [Homo sapiens]"
bao:BA0_0090012 "beta-1-adrenergic receptor [Homo sapiens]" ; # "has participant" -> "beta-1-adrenergic receptor [Homo sapiens]"
bao:BA0_0090012 "\"adrenergic, beta-2-, receptor, surface [Homo sapiens]\"" ; # "has participant" -> ""adrenergic, beta-2-, receptor, surface [Homo sapiens]""
bao:BA0_0090012 "androgen receptor [Rattus norvegicus]" ; # "has participant" -> "androgen receptor [Rattus norvegicus]"
bao:BA0_0090012 "bradykinin receptor B1 [Homo sapiens]" ; # "has participant" -> "bradykinin receptor B1 [Homo sapiens]"
bao:BA0_0090012 "bradykinin receptor B2 [Homo sapiens]" ; # "has participant" -> "bradykinin receptor B2 [Homo sapiens]"
bao:BA0_0090012 "Calcium channel L -type benzothiazepine [Rattus norvegicus]" ; # "has participant" -> "Calcium channel L -type benzothiazepine [Rattus norvegicus]"
bao:BA0_0090012 "\"calcium channel, voltage-dependent, alpha2/delta subunit 1 isoform 1 [Rattus norvegicus]\"" ; # "has participant" -> ""calcium channel, voltage-dependent, alpha2/delta subunit 1 isoform 1 [Rattus norvegicus]""
bao:BA0_0090012 "\"calcium channel, voltage-dependent, N type, alpha 1B subunit [Rattus norvegicus]\"" ; # "has participant" -> ""calcium channel, voltage-dependent, N type, alpha 1B subunit [Rattus norvegicus]""
bao:BA0_0090012 "dopamine receptor D1 [Homo sapiens]" ; # "has participant" -> "dopamine receptor D1 [Homo sapiens]"
bao:BA0_0090012 "dopamine receptor D2 isoform short [Homo sapiens]" ; # "has participant" -> "dopamine receptor D2 isoform short [Homo sapiens]"
bao:BA0_0090012 "dopamine receptor D4 [Homo sapiens]" ; # "has participant" -> "dopamine receptor D4 [Homo sapiens]"
bao:BA0_0090012 "dopamine receptor D3 isoform a [Homo sapiens]" ; # "has participant" -> "dopamine receptor D3 isoform a [Homo sapiens]"
bao:BA0_0090012 "endothelin receptor type A [Homo sapiens]" ; # "has participant" -> "endothelin receptor type A [Homo sapiens]"
bao:BA0_0090012 "endothelin receptor type B isoform 1 precursor [Homo sapiens]" ; # "has participant" -> "endothelin receptor type B isoform 1 precursor [Homo sapiens]"
bao:BA0_0090012 "Epidermal Growth Factor (beta-urogastrone) [Homo sapiens]" ; # "has participant" -> "Epidermal Growth Factor (beta-urogastrone) [Homo sapiens]"
bao:BA0_0090012 "estrogen receptor alpha isoform 1 [Homo sapiens]" ; # "has participant" -> "estrogen receptor alpha isoform 1 [Homo sapiens]"
bao:BA0_0090012 "G protein-coupled receptor 103 [Homo sapiens]" ; # "has participant" -> "G protein-coupled receptor 103 [Homo sapiens]"
bao:BA0_0090012 "gamma-aminobutyric acid (GABA) B receptor 1 isoform a precursor [Homo sapiens]" ; # "has participant" -> "gamma-aminobutyric acid (GABA) B receptor 1 isoform a precursor [Homo sapiens]"
bao:BA0_0090012 "\"GABAAFlunitrazepam, central [Rattus norvegicus]\"" ; # "has participant" -> ""GABAAFlunitrazepam, central [Rattus norvegicus]""
bao:BA0_0090012 "\"gamma-aminobutyric acid (GABA) A receptor, gamma 2 [Rattus norvegicus]\"" ; # "has participant" -> ""gamma-aminobutyric acid (GABA) A receptor, gamma 2 [Rattus norvegicus]""
bao:BA0_0090012 "\"nuclear receptor subfamily 3, group C, member 1 isoform alpha [Homo sapiens]\"" ; # "has participant" -> ""nuclear receptor subfamily 3, group C, member 1 isoform alpha [Homo sapiens]""
bao:BA0_0090012 "\"glutamate receptor, ionotropic, kainate 1 isoform 2 precursor [Rattus norvegicus]\"" ; # "has participant" -> ""glutamate receptor, ionotropic, kainate 1 isoform 2 precursor [Rattus norvegicus]""
bao:BA0_0090012 "\"glutamate receptor, ionotropic, N-methyl D-aspartate 1 [Rattus norvegicus]\"" ; # "has participant" -> ""glutamate receptor, ionotropic, N-methyl D-aspartate 1 [Rattus norvegicus]""
bao:BA0_0090012 "\"glutamate receptor, ionotropic, N-methyl D-aspartate 2B [Rattus norvegicus]\"" ; # "has participant" -> ""glutamate receptor, ionotropic, N-methyl D-aspartate 2B [Rattus norvegicus]""
bao:BA0_0090012 "\"glutamate receptor, ionotropic, NMDA2A (epsilon 1) [Mus musculus]\"" ; # "has participant" -> ""glutamate receptor, ionotropic, NMDA2A (epsilon 1) [Mus musculus]""
bao:BA0_0090012 "histamine receptor H1 [Homo sapiens]" ; # "has participant" -> "histamine receptor H1 [Homo sapiens]"
bao:BA0_0090012 "histamine receptor H2 isoform 2 [Homo sapiens]" ; # "has participant" -> "histamine receptor H2 isoform 2 [Homo sapiens]"
bao:BA0_0090012 "Histamine H3 [Homo sapiens]" ; # "has participant" -> "Histamine H3 [Homo sapiens]"
bao:BA0_0090012 "PREDICTED: similar to nischarin [Rattus norvegicus]" ; # "has participant" -> "PREDICTED: similar to nischarin [Rattus norvegicus]"
bao:BA0_0090012 "\"interleukin 1 receptor, type I isoform 1 [Mus musculus]\"" ; # "has participant" -> ""interleukin 1 receptor, type I isoform 1 [Mus musculus]""
bao:BA0_0090012 "cysteinyl leukotriene receptor 1 [Homo sapiens]" ; # "has participant" -> "cysteinyl leukotriene receptor 1 [Homo sapiens]"
bao:BA0_0090012 "melatonin receptor 1A [Homo sapiens]" ; # "has participant" -> "melatonin receptor 1A [Homo sapiens]"
bao:BA0_0090012 "\"cholinergic receptor, muscarinic 1 [Homo sapiens]\"" ; # "has participant" -> ""cholinergic receptor, muscarinic 1 [Homo sapiens]""
bao:BA0_0090012 "\"cholinergic receptor, muscarinic 2 [Homo sapiens]\"" ; # "has participant" -> ""cholinergic receptor, muscarinic 2 [Homo sapiens]""
bao:BA0_0090012 "\"cholinergic receptor, muscarinic 3 [Homo sapiens]\"" ; # "has participant" -> ""cholinergic receptor, muscarinic 3 [Homo sapiens]""
bao:BA0_0090012 "neuropeptide Y receptor Y1 [Homo sapiens]" ; # "has participant" -> "neuropeptide Y receptor Y1 [Homo sapiens]"
bao:BA0_0090012 "neuropeptide Y receptor Y2 [Homo sapiens]" ; # "has participant" -> "neuropeptide Y receptor Y2 [Homo sapiens]"
bao:BA0_0090012 "\"cholinergic receptor, nicotinic, alpha 3 [Homo sapiens]\"" ; # "has participant" -> ""cholinergic receptor, nicotinic, alpha 3 [Homo sapiens]""
bao:BA0_0090012 "nicotinic cholinergic receptor alpha 1 isoform b precursor [Homo sapiens]" ; # "has participant" -> "nicotinic cholinergic receptor alpha 1 isoform b precursor [Homo sapiens]"
bao:BA0_0090012 "\"opioid receptor, delta 1 [Homo sapiens]\"" ; # "has participant" -> ""opioid receptor, delta 1 [Homo sapiens]""
bao:BA0_0090012 "\"opioid receptor, kappa 1 [Homo sapiens]\"" ; # "has participant" -> ""opioid receptor, kappa 1 [Homo sapiens]""
bao:BA0_0090012 "\"opioid receptor, mu 1 isoform MOR-1 [Homo sapiens]\"" ; # "has participant" -> ""opioid receptor, mu 1 isoform MOR-1 [Homo sapiens]""
bao:BA0_0090012 "Phorbol Ester [Mus musculus]" ; # "has participant" -> "Phorbol Ester [Mus musculus]"
bao:BA0_0090012 "Platelet Activating Factor (PAF) [Homo sapiens]" ; # "has participant" -> "Platelet Activating Factor (PAF) [Homo sapiens]"
bao:BA0_0090012 "G protein-activated inward rectifier potassium channel 2 GIRK2 [Mesocricetus auratus (golden hamster)]" ; # "has participant" -> "G protein-activated inward rectifier potassium channel 2 GIRK2 [Mesocricetus auratus (golden hamster)]"
bao:BA0_0090012 "\"voltage-gated potassium channel, subfamily H, member 2 isoform a [Homo sapiens]\"" ; # "has participant" -> ""voltage-gated potassium channel, subfamily H, member 2 isoform a [Homo sapiens]""
bao:BA0_0090012 "\"Prostanoid E receptor 4, subtype EP4 [Homo sapiens]\"" ; # "has participant" -> ""Prostanoid E receptor 4, subtype EP4 [Homo sapiens]""
bao:BA0_0090012 "Purinergic P2X [Oryctolagus cuniculus (rabbit)]" ; # "has participant" -> "Purinergic P2X [Oryctolagus cuniculus (rabbit)]"
bao:BA0_0090012 "\"purinergic receptor P2Y, G-protein coupled 1 [Rattus norvegicus]\"" ; # "has participant" -> ""purinergic receptor P2Y, G-protein coupled 1 [Rattus norvegicus]""
bao:BA0_0090012 "Rolipram [Rattus norvegicus]" ; # "has participant" -> "Rolipram [Rattus norvegicus]"
bao:BA0_0090012 "5-hydroxytryptamine (serotonin) receptor 1A [Homo sapiens]" ; # "has participant" -> "5-hydroxytryptamine (serotonin) receptor 1A [Homo sapiens]"
bao:BA0_0090012 "5-Hydroxytryptamine (serotonin) receptor 3A isoform b precursor [Homo sapiens]" ; # "has participant" -> "5-Hydroxytryptamine (serotonin) receptor 3A isoform b precursor [Homo sapiens]"
bao:BA0_0090012 "sigma non-opioid intracellular receptor 1 isoform 1 [Homo sapiens]" ; # "has participant" -> "sigma non-opioid intracellular receptor 1 isoform 1 [Homo sapiens]"
bao:BA0_0090012 "\"opioid receptor, sigma 1 [Rattus norvegicus]\"" ; # "has participant" -> ""opioid receptor, sigma 1 [Rattus norvegicus]""
bao:BA0_0090012 "\"sodium channel, voltage-gated, type I, alpha [Rattus norvegicus]\"" ; # "has participant" -> ""sodium channel, voltage-gated, type I, alpha [Rattus norvegicus]""
bao:BA0_0090012 "tachykinin receptor 1 isoform long [Homo sapiens]" ; # "has participant" -> "tachykinin receptor 1 isoform long [Homo sapiens]"
bao:BA0_0090012 "c-erbA-alpha2 isoform TRalpha2 [Rattus norvegicus]" ; # "has participant" -> "c-erbA-alpha2 isoform TRalpha2 [Rattus norvegicus]"
bao:BA0_0090012 "\"solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 [Homo sapiens]\"" ; # "has participant" -> ""solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 [Homo sapiens]""
bao:BA0_0090012 "vesicular inhibitory amino acid transporter [Rattus norvegicus]" ; # "has participant" -> "vesicular inhibitory amino acid transporter [Rattus norvegicus]"
bao:BA0_0090012 "solute carrier family 6 member 2 [Homo sapiens]" ; # "has participant" -> "solute carrier family 6 member 2 [Homo sapiens]"
bao:BA0_0090012 "solute carrier family 6 member 4 [Homo sapiens]" ; # "has participant" -> "solute carrier family 6 member 4 [Homo sapiens]"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0000337 bao:BAO_0000201 ; # "has percent response" -> "percent inhibition"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has concentration unit" -> "percent"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2" ; # "PubChem TID" -> "2"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "4" ; # "PubChem TID" -> "4"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "6" ; # "PubChem TID" -> "6"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "8" ; # "PubChem TID" -> "8"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10" ; # "PubChem TID" -> "10"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "12" ; # "PubChem TID" -> "12"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "14" ; # "PubChem TID" -> "14"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "16" ; # "PubChem TID" -> "16"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "18" ; # "PubChem TID" -> "18"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "20" ; # "PubChem TID" -> "20"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "22" ; # "PubChem TID" -> "22"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "24" ; # "PubChem TID" -> "24"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "26" ; # "PubChem TID" -> "26"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "28" ; # "PubChem TID" -> "28"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "30" ; # "PubChem TID" -> "30"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "32" ; # "PubChem TID" -> "32"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "34" ; # "PubChem TID" -> "34"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "36" ; # "PubChem TID" -> "36"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "38" ; # "PubChem TID" -> "38"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "40" ; # "PubChem TID" -> "40"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "42" ; # "PubChem TID" -> "42"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "44" ; # "PubChem TID" -> "44"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "46" ; # "PubChem TID" -> "46"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "48" ; # "PubChem TID" -> "48"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "50" ; # "PubChem TID" -> "50"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "52" ; # "PubChem TID" -> "52"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "54" ; # "PubChem TID" -> "54"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "56" ; # "PubChem TID" -> "56"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "58" ; # "PubChem TID" -> "58"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "60" ; # "PubChem TID" -> "60"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "62" ; # "PubChem TID" -> "62"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "64" ; # "PubChem TID" -> "64"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "66" ; # "PubChem TID" -> "66"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "68" ; # "PubChem TID" -> "68"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "70" ; # "PubChem TID" -> "70"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "72" ; # "PubChem TID" -> "72"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "74" ; # "PubChem TID" -> "74"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "76" ; # "PubChem TID" -> "76"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "78" ; # "PubChem TID" -> "78"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "80" ; # "PubChem TID" -> "80"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "82" ; # "PubChem TID" -> "82"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "84" ; # "PubChem TID" -> "84"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "86" ; # "PubChem TID" -> "86"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "88" ; # "PubChem TID" -> "88"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "90" ; # "PubChem TID" -> "90"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "92" ; # "PubChem TID" -> "92"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "94" ; # "PubChem TID" -> "94"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "96" ; # "PubChem TID" -> "96"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "98" ; # "PubChem TID" -> "98"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "100" ; # "PubChem TID" -> "100"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "102" ; # "PubChem TID" -> "102"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "104" ; # "PubChem TID" -> "104"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "106" ; # "PubChem TID" -> "106"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "108" ; # "PubChem TID" -> "108"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "110" ; # "PubChem TID" -> "110"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "112" ; # "PubChem TID" -> "112"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "114" ; # "PubChem TID" -> "114"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "116" ; # "PubChem TID" -> "116"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "118" ; # "PubChem TID" -> "118"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "120" ; # "PubChem TID" -> "120"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "122" ; # "PubChem TID" -> "122"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "124" ; # "PubChem TID" -> "124"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "126" ; # "PubChem TID" -> "126"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "128" ; # "PubChem TID" -> "128"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "130" ; # "PubChem TID" -> "130"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "132" ; # "PubChem TID" -> "132"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "134" ; # "PubChem TID" -> "134"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "136" ; # "PubChem TID" -> "136"
bao:BAO_0002666 "10" ; # "has concentration value" -> "10"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
bao:BAO_0002845 "1" ; # "has repetition point-number" -> "1"
bao:BAO_0000196 bao:BAO_0000537 ; # "has mode of action" -> "allosteric binding"
bao:BAO_0002864 bao:BAO_0000136 ; # "has repetition throughput" -> "single repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "mp" ; # "Annotated by" -> "mp"
